Buccal Drug Delivery Systems Market Size, Share & Trends Analysis Report By Type (Buccal Tablets & Lozenges, Sublingual Films), By Application, By End-user, By Region, And Segment Forecasts, 2021 - 2028
This report can be delivered to the clients within 72 Business Hours
Buccal Drug Delivery Systems Market Growth & Trends
The global buccal drug delivery systems market size is expected to reach USD 5.9 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 9.2% from 2021 to 2028. Buccal drug delivery systems have gained significant momentum since the last decade. Elimination of first-pass metabolism, quick absorption of the pH-sensitive drug, no interaction with stomach acid, quicker onset of action than any oral dose, minimal side effects, and reduced drug degradation are some of the factors fueling the market growth. Buccal drug delivery has gained large acceptance among geriatric patients and patients having difficulty swallowing.
Leading players like Generex, NovaDel, Biodiversity Sciences International, and Transcept Pharmaceuticals are constantly developing critical drugs like insulin, heparin, morphine, long-lasting pain analgesics, and some anti cardiac drugs into rapid mists, mucoadhesive discs, and lozenges. Commercialization of this research would eventually lead to being a major life savior as it would ensure the faster onset of action and eliminate drug degradation. Despite the increased R&D activity among market players, asteep decline was observed in the sales and revenue gainsdue to the outbreak of the Covid-19 pandemic. Except for covid medications, several other drug markets were majorly hit leading to the dip in the market for buccal drug delivery. However, it is expected to bounce back by 2022.
Buccal Drug Delivery Systems Market Report Highlights
Buccal Drug Delivery Systems Market Growth & Trends
The global buccal drug delivery systems market size is expected to reach USD 5.9 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 9.2% from 2021 to 2028. Buccal drug delivery systems have gained significant momentum since the last decade. Elimination of first-pass metabolism, quick absorption of the pH-sensitive drug, no interaction with stomach acid, quicker onset of action than any oral dose, minimal side effects, and reduced drug degradation are some of the factors fueling the market growth. Buccal drug delivery has gained large acceptance among geriatric patients and patients having difficulty swallowing.
Leading players like Generex, NovaDel, Biodiversity Sciences International, and Transcept Pharmaceuticals are constantly developing critical drugs like insulin, heparin, morphine, long-lasting pain analgesics, and some anti cardiac drugs into rapid mists, mucoadhesive discs, and lozenges. Commercialization of this research would eventually lead to being a major life savior as it would ensure the faster onset of action and eliminate drug degradation. Despite the increased R&D activity among market players, asteep decline was observed in the sales and revenue gainsdue to the outbreak of the Covid-19 pandemic. Except for covid medications, several other drug markets were majorly hit leading to the dip in the market for buccal drug delivery. However, it is expected to bounce back by 2022.
Buccal Drug Delivery Systems Market Report Highlights
- The buccal tablets and lozenges type segment accounted for the largest revenue share in 2020 due to its wider acceptance among patients
- The smoking cessation application segment held the largest share in 2020. Buccal drug delivery is often the most preferred and effective formulation for treating patients with smoking or nicotine addiction
- The hospital end-user segment captured the largest revenue share in 2020 owing to a large number of admissions of geriatric patients and abundant medication supplies
- North America held the largest revenue share in 2020 due to a large number of leading manufacturers and growing research in the region
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation & Scope
1.1.1. Type
1.1.2. Application
1.1.3. End User
1.1.4. Region
1.1.5. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.5.1. Data for primary interviews in North America
1.3.5.2. Data for primary interviews in Europe
1.3.5.3. Data for primary interviews in Asia Pacific
1.3.5.4. Data for primary interviews in Latin America
1.3.5.5. Data for Primary interviews in MEA
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective
1.9.2. Objective
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Type outlook
2.2.2. Application outlook
2.2.3. End-user outlook
2.2.4. Regional outlook
2.3. Competitive Insights
CHAPTER 3. BUCCAL DRUG DELIVERY SYSTEM MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
3.3.1. Reimbursement framework
3.4. Market Dynamics
3.4.1. Market driver analysis
3.4.1.1. Improved research in this field
3.4.1.2. Large number of market players
3.4.2. Market restraint analysis
3.4.2.1. Critical formulation process
3.5. Buccal drug delivery system Market Analysis Tools
3.5.1. Industry Analysis - Porter’s
3.5.1.1. Supplier power
3.5.1.2. Buyer power
3.5.1.3. Substitution threat
3.5.1.4. Threat of new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL Analysis
3.5.2.1. Political landscape
3.5.2.2. Technological landscape
3.5.2.3. Economic landscape
3.5.3. Major Deals & Strategic Alliances Analysis
3.5.4. Market Entry Strategies
CHAPTER 4. BUCCAL DRUG DELIVERY SYSTEM: TYPE ESTIMATES & TREND ANALYSIS
4.1. Definitions and Scope
4.1.1. Sublingual Films
4.1.2. Buccal tablets and lozenges
4.1.3. Oral sprays
4.2. Buccal drug delivery system Market Share, 2021 & 2028
4.3. Segment Dashboard
4.4. Global Buccal drug delivery system Market by Type Outlook
4.5. Market Size & Forecasts and Trend Analyses, 2016 to 2028 for the following
4.5.1. Sublingual films
4.5.1.1. Sublingual film-based Market estimates and forecast 2016 to 2028 (USD Million)
4.5.2. Buccal tablets and lozenges
4.5.2.1. Buccal tablets and lozenges-based Market estimates and forecast 2016 to 2028 (USD Million)
4.5.3. Oral Sprays
4.5.3.1. Oral sprays-based Market estimates and forecast 2016 to 2028 (USD Million)
CHAPTER 5. BUCCAL DRUG DELIVERY SYSTEM: APPLICATION ESTIMATES & TREND ANALYSIS
5.1. Definitions and Scope
5.1.1. Pain Management
5.1.2. Smoking Cessation
5.1.3. Angina Pectoris
5.1.4. Others
5.2. Buccal drug delivery system Market Share, 2021 & 2028
5.3. Segment Dashboard
5.4. Global Buccal drug delivery system Market by application Outlook
5.5. Market Size & Forecasts and Trend Analyses, 2016 to 2028 for the following
5.5.1. Pain management
5.5.1.1. Pain management Market estimates and forecast 2016 to 2028 (USD Million)
5.5.2. Smoking Cessation
5.5.2.1. Smoking Cessation Market estimates and forecast 2016 to 2028 (USD Million)
5.5.3. Angina Pectoris
5.5.3.1. Angina Pectoris Market estimates and forecast 2016 to 2028 (USD Million)
5.5.4. Others
5.5.4.1. Others Market estimates and forecast 2016 to 2028 (USD Million)
CHAPTER 6. BUCCAL DRUG DELIVERY SYSTEM: END-USER ESTIMATES & TREND ANALYSIS
6.1. Definitions and Scope
6.2. Hospitals
6.3. Ambulatory centers
6.4. Others
6.5. Buccal drug delivery system Market Share, 2021 & 2028
6.6. Segment Dashboard
6.7. Global Buccal drug delivery system Market by end-user Outlook
6.8. Market Size & Forecasts and Trend Analyses, 2016 to 2028 for the following
6.8.1. Hospitals
6.8.1.1. Pharmaceutical companies market estimates and forecast 2016 to 2028 (USD Million)
6.8.2. Ambulatory centers
6.8.2.1. Ambulatory centers market estimates and forecast 2016 to 2028 (USD Million)
6.8.3. Others
6.8.3.1. Others market estimates and forecast 2016 to 2028 (USD Million)
CHAPTER 7. BUCCAL DRUG DELIVERY SYSTEM MARKET: REGIONAL ESTIMATES & TREND ANALYSIS
7.1. Regional market share analysis, 2020 & 2028
7.2. Regional Market Dashboard
7.3. Global Regional Market Snapshot
7.4. Regional Market Share and Leading Players, 2020
7.4.1. North America
7.4.2. Europe
7.4.3. Asia Pacific
7.4.4. Latin America
7.4.5. Middle East and Africa
7.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
7.5.1. North America
7.5.2. Europe
7.5.3. Asia Pacific
7.5.4. Latin America
7.5.5. Middle East and Africa
7.6. Market Size, & Forecasts, Volume and Trend Analysis, 2020 & 2028:
7.7. North America
7.7.1. Market estimates and forecast, 2016 - 2028 (USD Million)
7.7.2. U.S.
7.7.2.1. Market estimates and forecast, 2016 - 2028 (USD Million)
7.7.3. Canada
7.7.3.1. Market estimates and forecast, 2016 - 2028 (USD Million)
7.8. Europe
7.8.1. U.K.
7.8.1.1. Market estimates and forecast, 2016 - 2028 (USD Million)
7.8.2. Germany
7.8.2.1. Market estimates and forecast, 2016 - 2028 (USD Million)
7.8.3. France
7.8.3.1. Market estimates and forecast, 2016 - 2028 (USD Million)
7.8.4. Italy
7.8.4.1. Market estimates and forecast, 2016 - 2028 (USD Million)
7.8.5. Spain
7.8.5.1. Market estimates and forecast, 2016 - 2028 (USD Million)
7.8.6. Norway
7.8.6.1. Market estimates and forecast, 2016 - 2028 (USD Million)
7.8.7. Sweden
7.8.7.1. Market estimates and forecast, 2016 - 2028 (USD Million)
7.8.8. Russia
7.8.8.1. Market estimates and forecast, 2016 - 2028 (USD Million)
7.9. Asia Pacific
7.9.1. Japan
7.9.1.1. Market estimates and forecast, 2016 - 2028 (USD Million)
7.9.2. China
7.9.2.1. Market estimates and forecast, 2016 - 2028 (USD Million)
7.9.3. India
7.9.3.1. Market estimates and forecast, 2016 - 2028 (USD Million)
7.9.4. Thailand
7.9.4.1. Market estimates and forecast, 2016 - 2028 (USD Million)
7.9.5. South Korea
7.9.5.1. Market estimates and forecast, 2016 - 2028 (USD Million)
7.9.6. Australia
7.9.6.1. Market estimates and forecast, 2016 - 2028 (USD Million)
7.10. Latin America
7.10.1. Brazil
7.10.1.1. Market estimates and forecast, 2016 - 2028 (USD Million)
7.10.2. Mexico
7.10.2.1. Market estimates and forecast, 2016 - 2028 (USD Million)
7.10.3. Argentina
7.10.3.1. Market estimates and forecast, 2016 - 2028 (USD Million)
7.11. MEA
7.11.1. South Africa
7.11.1.1. Market estimates and forecast, 2016 - 2028 (USD Million)
7.11.2. Saudi Arabia
7.11.2.1. Market estimates and forecast, 2016 - 2028 (USD Million)
7.11.3. UAE
7.11.3.1. Market estimates and forecast, 2016 - 2028 (USD Million)
7.11.4. Turkey
7.11.4.1. Market estimates and forecast, 2016 - 2028 (USD Million)
CHAPTER 8. COMPETITIVE LANDSCAPE
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.2.1. Innovators
8.3. Vendor Landscape
8.3.1. List of key distributors and channel partners
8.3.2. Key customers
8.3.3. Key company market share analysis, 2020
8.3.4. Teva Pharmaceutical Industries Ltd.
8.3.4.1. Company overview
8.3.4.2. Financial performance
8.3.4.3. Product benchmarking
8.3.4.4. Strategic initiatives
8.3.5. Pfizer Inc.
8.3.5.1. Company overview
8.3.5.2. Financial performance
8.3.5.3. Product benchmarking
8.3.5.4. Strategic initiatives
8.3.6. Glaxo Smith Klein
8.3.6.1. Company overview
8.3.6.2. Financial performance
8.3.6.3. Product benchmarking
8.3.6.4. Strategic initiatives
8.3.7. Indivior Pharmaceuticals
8.3.7.1. Company overview
8.3.7.2. Financial performance
8.3.7.3. Product benchmarking
8.3.7.4. Strategic initiatives
8.3.8. Catalent
8.3.8.1. Company overview
8.3.8.2. Financial performance
8.3.8.3. Product benchmarking
8.3.8.4. Strategic initiatives
8.3.9. Generex Biotechnology
8.3.9.1. Company overview
8.3.9.2. Financial performance
8.3.9.3. Product benchmarking
8.3.9.4. Strategic initiatives
8.3.10. Biodelivery Sciences International, Inc.
8.3.10.1. Company overview
8.3.10.2. Financial performance
8.3.10.3. Product benchmarking
8.3.10.4. Strategic initiatives
8.3.11. Endo Pharmaceuticals
8.3.11.1. Company overview
8.3.11.2. Financial performance
8.3.11.3. Product benchmarking
8.3.11.4. Strategic initiatives
8.3.12. ARx LLC
8.3.12.1. Company overview
8.3.12.2. Financial performance
8.3.12.3. Product benchmarking
8.3.12.4. Strategic initiatives
8.3.13. Cynapsus Therapeutic Inc.
8.3.13.1. Company overview
8.3.13.2. Financial performance
8.3.13.3. Product benchmarking
8.3.13.4. Strategic initiatives
1.1. Market Segmentation & Scope
1.1.1. Type
1.1.2. Application
1.1.3. End User
1.1.4. Region
1.1.5. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.5.1. Data for primary interviews in North America
1.3.5.2. Data for primary interviews in Europe
1.3.5.3. Data for primary interviews in Asia Pacific
1.3.5.4. Data for primary interviews in Latin America
1.3.5.5. Data for Primary interviews in MEA
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective
1.9.2. Objective
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Type outlook
2.2.2. Application outlook
2.2.3. End-user outlook
2.2.4. Regional outlook
2.3. Competitive Insights
CHAPTER 3. BUCCAL DRUG DELIVERY SYSTEM MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
3.3.1. Reimbursement framework
3.4. Market Dynamics
3.4.1. Market driver analysis
3.4.1.1. Improved research in this field
3.4.1.2. Large number of market players
3.4.2. Market restraint analysis
3.4.2.1. Critical formulation process
3.5. Buccal drug delivery system Market Analysis Tools
3.5.1. Industry Analysis - Porter’s
3.5.1.1. Supplier power
3.5.1.2. Buyer power
3.5.1.3. Substitution threat
3.5.1.4. Threat of new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL Analysis
3.5.2.1. Political landscape
3.5.2.2. Technological landscape
3.5.2.3. Economic landscape
3.5.3. Major Deals & Strategic Alliances Analysis
3.5.4. Market Entry Strategies
CHAPTER 4. BUCCAL DRUG DELIVERY SYSTEM: TYPE ESTIMATES & TREND ANALYSIS
4.1. Definitions and Scope
4.1.1. Sublingual Films
4.1.2. Buccal tablets and lozenges
4.1.3. Oral sprays
4.2. Buccal drug delivery system Market Share, 2021 & 2028
4.3. Segment Dashboard
4.4. Global Buccal drug delivery system Market by Type Outlook
4.5. Market Size & Forecasts and Trend Analyses, 2016 to 2028 for the following
4.5.1. Sublingual films
4.5.1.1. Sublingual film-based Market estimates and forecast 2016 to 2028 (USD Million)
4.5.2. Buccal tablets and lozenges
4.5.2.1. Buccal tablets and lozenges-based Market estimates and forecast 2016 to 2028 (USD Million)
4.5.3. Oral Sprays
4.5.3.1. Oral sprays-based Market estimates and forecast 2016 to 2028 (USD Million)
CHAPTER 5. BUCCAL DRUG DELIVERY SYSTEM: APPLICATION ESTIMATES & TREND ANALYSIS
5.1. Definitions and Scope
5.1.1. Pain Management
5.1.2. Smoking Cessation
5.1.3. Angina Pectoris
5.1.4. Others
5.2. Buccal drug delivery system Market Share, 2021 & 2028
5.3. Segment Dashboard
5.4. Global Buccal drug delivery system Market by application Outlook
5.5. Market Size & Forecasts and Trend Analyses, 2016 to 2028 for the following
5.5.1. Pain management
5.5.1.1. Pain management Market estimates and forecast 2016 to 2028 (USD Million)
5.5.2. Smoking Cessation
5.5.2.1. Smoking Cessation Market estimates and forecast 2016 to 2028 (USD Million)
5.5.3. Angina Pectoris
5.5.3.1. Angina Pectoris Market estimates and forecast 2016 to 2028 (USD Million)
5.5.4. Others
5.5.4.1. Others Market estimates and forecast 2016 to 2028 (USD Million)
CHAPTER 6. BUCCAL DRUG DELIVERY SYSTEM: END-USER ESTIMATES & TREND ANALYSIS
6.1. Definitions and Scope
6.2. Hospitals
6.3. Ambulatory centers
6.4. Others
6.5. Buccal drug delivery system Market Share, 2021 & 2028
6.6. Segment Dashboard
6.7. Global Buccal drug delivery system Market by end-user Outlook
6.8. Market Size & Forecasts and Trend Analyses, 2016 to 2028 for the following
6.8.1. Hospitals
6.8.1.1. Pharmaceutical companies market estimates and forecast 2016 to 2028 (USD Million)
6.8.2. Ambulatory centers
6.8.2.1. Ambulatory centers market estimates and forecast 2016 to 2028 (USD Million)
6.8.3. Others
6.8.3.1. Others market estimates and forecast 2016 to 2028 (USD Million)
CHAPTER 7. BUCCAL DRUG DELIVERY SYSTEM MARKET: REGIONAL ESTIMATES & TREND ANALYSIS
7.1. Regional market share analysis, 2020 & 2028
7.2. Regional Market Dashboard
7.3. Global Regional Market Snapshot
7.4. Regional Market Share and Leading Players, 2020
7.4.1. North America
7.4.2. Europe
7.4.3. Asia Pacific
7.4.4. Latin America
7.4.5. Middle East and Africa
7.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
7.5.1. North America
7.5.2. Europe
7.5.3. Asia Pacific
7.5.4. Latin America
7.5.5. Middle East and Africa
7.6. Market Size, & Forecasts, Volume and Trend Analysis, 2020 & 2028:
7.7. North America
7.7.1. Market estimates and forecast, 2016 - 2028 (USD Million)
7.7.2. U.S.
7.7.2.1. Market estimates and forecast, 2016 - 2028 (USD Million)
7.7.3. Canada
7.7.3.1. Market estimates and forecast, 2016 - 2028 (USD Million)
7.8. Europe
7.8.1. U.K.
7.8.1.1. Market estimates and forecast, 2016 - 2028 (USD Million)
7.8.2. Germany
7.8.2.1. Market estimates and forecast, 2016 - 2028 (USD Million)
7.8.3. France
7.8.3.1. Market estimates and forecast, 2016 - 2028 (USD Million)
7.8.4. Italy
7.8.4.1. Market estimates and forecast, 2016 - 2028 (USD Million)
7.8.5. Spain
7.8.5.1. Market estimates and forecast, 2016 - 2028 (USD Million)
7.8.6. Norway
7.8.6.1. Market estimates and forecast, 2016 - 2028 (USD Million)
7.8.7. Sweden
7.8.7.1. Market estimates and forecast, 2016 - 2028 (USD Million)
7.8.8. Russia
7.8.8.1. Market estimates and forecast, 2016 - 2028 (USD Million)
7.9. Asia Pacific
7.9.1. Japan
7.9.1.1. Market estimates and forecast, 2016 - 2028 (USD Million)
7.9.2. China
7.9.2.1. Market estimates and forecast, 2016 - 2028 (USD Million)
7.9.3. India
7.9.3.1. Market estimates and forecast, 2016 - 2028 (USD Million)
7.9.4. Thailand
7.9.4.1. Market estimates and forecast, 2016 - 2028 (USD Million)
7.9.5. South Korea
7.9.5.1. Market estimates and forecast, 2016 - 2028 (USD Million)
7.9.6. Australia
7.9.6.1. Market estimates and forecast, 2016 - 2028 (USD Million)
7.10. Latin America
7.10.1. Brazil
7.10.1.1. Market estimates and forecast, 2016 - 2028 (USD Million)
7.10.2. Mexico
7.10.2.1. Market estimates and forecast, 2016 - 2028 (USD Million)
7.10.3. Argentina
7.10.3.1. Market estimates and forecast, 2016 - 2028 (USD Million)
7.11. MEA
7.11.1. South Africa
7.11.1.1. Market estimates and forecast, 2016 - 2028 (USD Million)
7.11.2. Saudi Arabia
7.11.2.1. Market estimates and forecast, 2016 - 2028 (USD Million)
7.11.3. UAE
7.11.3.1. Market estimates and forecast, 2016 - 2028 (USD Million)
7.11.4. Turkey
7.11.4.1. Market estimates and forecast, 2016 - 2028 (USD Million)
CHAPTER 8. COMPETITIVE LANDSCAPE
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.2.1. Innovators
8.3. Vendor Landscape
8.3.1. List of key distributors and channel partners
8.3.2. Key customers
8.3.3. Key company market share analysis, 2020
8.3.4. Teva Pharmaceutical Industries Ltd.
8.3.4.1. Company overview
8.3.4.2. Financial performance
8.3.4.3. Product benchmarking
8.3.4.4. Strategic initiatives
8.3.5. Pfizer Inc.
8.3.5.1. Company overview
8.3.5.2. Financial performance
8.3.5.3. Product benchmarking
8.3.5.4. Strategic initiatives
8.3.6. Glaxo Smith Klein
8.3.6.1. Company overview
8.3.6.2. Financial performance
8.3.6.3. Product benchmarking
8.3.6.4. Strategic initiatives
8.3.7. Indivior Pharmaceuticals
8.3.7.1. Company overview
8.3.7.2. Financial performance
8.3.7.3. Product benchmarking
8.3.7.4. Strategic initiatives
8.3.8. Catalent
8.3.8.1. Company overview
8.3.8.2. Financial performance
8.3.8.3. Product benchmarking
8.3.8.4. Strategic initiatives
8.3.9. Generex Biotechnology
8.3.9.1. Company overview
8.3.9.2. Financial performance
8.3.9.3. Product benchmarking
8.3.9.4. Strategic initiatives
8.3.10. Biodelivery Sciences International, Inc.
8.3.10.1. Company overview
8.3.10.2. Financial performance
8.3.10.3. Product benchmarking
8.3.10.4. Strategic initiatives
8.3.11. Endo Pharmaceuticals
8.3.11.1. Company overview
8.3.11.2. Financial performance
8.3.11.3. Product benchmarking
8.3.11.4. Strategic initiatives
8.3.12. ARx LLC
8.3.12.1. Company overview
8.3.12.2. Financial performance
8.3.12.3. Product benchmarking
8.3.12.4. Strategic initiatives
8.3.13. Cynapsus Therapeutic Inc.
8.3.13.1. Company overview
8.3.13.2. Financial performance
8.3.13.3. Product benchmarking
8.3.13.4. Strategic initiatives
LIST OF TABLES
Table 1 List of Abbreviation
Table 2 North America Buccal drug delivery system market, by country, 2016 - 2028 (USD Million)
Table 3 North America Buccal drug delivery system market, by type, 2016 - 2028 (USD Million)
Table 4 North America Buccal drug delivery system market, by application, 2016 - 2028 (USD Million)
Table 5 North America Buccal drug delivery system market, by end user, 2016 - 2028 (USD Million)
Table 6 U.S. Buccal drug delivery system market, by type 2016 - 2028 (USD Million)
Table 7 U.S. Buccal drug delivery system market, by application, 2016 - 2028 (USD Million)
Table 8 U.S. Buccal drug delivery system market, by end user, 2016 - 2028 (USD Million)
Table 9 Canada Buccal drug delivery system market, by type 2016 - 2028 (USD Million)
Table 10 Canada Buccal drug delivery system market, by application, 2016 - 2028 (USD Million)
Table 11 Canada Buccal drug delivery system market, by end user, 2016 - 2028 (USD Million)
Table 12 Europe Buccal drug delivery system market, by country, 2016 - 2028 (USD Million)
Table 13 Europe Buccal drug delivery system market, by type 2016 - 2028 (USD Million)
Table 14 Europe Buccal drug delivery system market, by application, 2016 - 2028 (USD Million)
Table 15 Europe Buccal drug delivery system market, by end user, 2016 - 2028 (USD Million)
Table 16 Germany Buccal drug delivery system market, by type 2016 - 2028 (USD Million)
Table 17 Germany Buccal drug delivery system market, by application, 2016 - 2028 (USD Million)
Table 18 Germany Buccal drug delivery system market, by end user, 2016 - 2028 (USD Million)
Table 19 France Buccal drug delivery system market, by type 2016 - 2028 (USD Million)
Table 20 France Buccal drug delivery system market, by application, 2016 - 2028 (USD Million)
Table 21 France Buccal drug delivery system market, by end user, 2016 - 2028 (USD Million)
Table 22 Italy Buccal drug delivery system market, by type 2016 - 2028 (USD Million)
Table 23 Italy Buccal drug delivery system market, by application, 2016 - 2028 (USD Million)
Table 24 Italy Buccal drug delivery system market, by end user, 2016 - 2028 (USD Million)
Table 25 Spain Buccal drug delivery system market, by type 2016 - 2028 (USD Million)
Table 26 Spain Buccal drug delivery system market, by application, 2016 - 2028 (USD Million)
Table 27 Spain a Buccal drug delivery system market, by end user, 2016 - 2028 (USD Million)
Table 28 U.K. Buccal drug delivery system market, by type 2016 - 2028 (USD Million)
Table 29 U.K. Buccal drug delivery system market, by application, 2016 - 2028 (USD Million)
Table 30 U.K. Buccal drug delivery system market, by end user, 2016 - 2028 (USD Million)
Table 31 Norway Buccal drug delivery system market, by type 2016 - 2028 (USD Million)
Table 32 Norway Buccal drug delivery system market, by application, 2016 - 2028 (USD Million)
Table 33 Norway Buccal drug delivery system market, by end user, 2016 - 2028 (USD Million)
Table 34 Sweden Buccal drug delivery system market, by type 2016 - 2028 (USD Million)
Table 35 Sweden Buccal drug delivery system market, by application, 2016 - 2028 (USD Million)
Table 36 Sweden Buccal drug delivery system market, by end user, 2016 - 2028 (USD Million)
Table 37 Russia Buccal drug delivery system market, by type 2016 - 2028 (USD Million)
Table 38 Russia Buccal drug delivery system market, by application, 2016 - 2028 (USD Million)
Table 39 Russia a Buccal drug delivery system market, by end user, 2016 - 2028 (USD Million)
Table 40 Asia Pacific Buccal drug delivery system market, by country, 2016 - 2028 (USD Million)
Table 41 Asia Pacific Buccal drug delivery system market, by type 2016 - 2028 (USD Million)
Table 42 Asia Pacific Buccal drug delivery system market, by application, 2016 - 2028 (USD Million)
Table 43 Asia Pacific Buccal drug delivery system market, by end user, 2016 - 2028 (USD Million)
Table 44 Japan Buccal drug delivery system market, by type 2016 - 2028 (USD Million)
Table 45 Japan Buccal drug delivery system market, by application, 2016 - 2028 (USD Million)
Table 46 Japan Buccal drug delivery system market, by end user, 2016 - 2028 (USD Million)
Table 47 China Buccal drug delivery system market, by type 2016 - 2028 (USD Million)
Table 48 China Buccal drug delivery system market, by application, 2016 - 2028 (USD Million)
Table 49 China Buccal drug delivery system market, by end user, 2016 - 2028 (USD Million)
Table 50 India Buccal drug delivery system market, by type 2016 - 2028 (USD Million)
Table 51 India Buccal drug delivery system market, by application, 2016 - 2028 (USD Million)
Table 52 India Buccal drug delivery system market, by end user, 2016 - 2028 (USD Million)
Table 53 Australia Buccal drug delivery system market, by type 2016 - 2028 (USD Million)
Table 54 Australia Buccal drug delivery system market, by application, 2016 - 2028 (USD Million)
Table 55 Australia Buccal drug delivery system market, by end user, 2016 - 2028 (USD Million)
Table 56 South Korea Buccal drug delivery system market, by type 2016 - 2028 (USD Million)
Table 57 South Korea Buccal drug delivery system market, by application, 2016 - 2028 (USD Million)
Table 58 South Korea Buccal drug delivery system market, by end user, 2016 - 2028 (USD Million)
Table 59 Thailand Buccal drug delivery system market, by type 2016 - 2028 (USD Million)
Table 60 Thailand Buccal drug delivery system market, by application, 2016 - 2028 (USD Million)
Table 61 Thailand Buccal drug delivery system market, by end user, 2016 - 2028 (USD Million)
Table 62 Latin America Buccal drug delivery system market, by country, 2016 - 2028 (USD Million)
Table 63 Latin America Buccal drug delivery system market, by type 2016 - 2028 (USD Million)
Table 64 Latin America Buccal drug delivery system market, by application, 2016 - 2028 (USD Million)
Table 65 Latin America Buccal drug delivery system market, by end user, 2016 - 2028 (USD Million)
Table 66 Mexico Buccal drug delivery system market, by type 2016 - 2028 (USD Million)
Table 67 Mexico Buccal drug delivery system market, by application, 2016 - 2028 (USD Million)
Table 68 Mexico Buccal drug delivery system market, by end user, 2016 - 2028 (USD Million)
Table 69 Brazil Buccal drug delivery system market, by type 2016 - 2028 (USD Million)
Table 70 Brazil Buccal drug delivery system market, by application, 2016 - 2028 (USD Million)
Table 71 Brazil Buccal drug delivery system market, by end user, 2016 - 2028 (USD Million)
Table 72 Argentina Buccal drug delivery system market, by type 2016 - 2028 (USD Million)
Table 73 Argentina Buccal drug delivery system market, by application, 2016 - 2028 (USD Million)
Table 74 Argentina Buccal drug delivery system market, by end user, 2016 - 2028 (USD Million)
Table 75 Middle East and Africa Buccal drug delivery system market, by country, 2016 - 2028 (USD Million)
Table 76 Middle East and Africa Buccal drug delivery system market, by type 2016 - 2028 (USD Million)
Table 77 Middle East and Africa Buccal drug delivery system market, by application, 2016 - 2028 (USD Million)
Table 78 Middle East and Africa Buccal drug delivery system market, by end user, 2016 - 2028 (USD Million)
Table 79 South Africa Buccal drug delivery system market, by type 2016 - 2028 (USD Million)
Table 80 South Africa Buccal drug delivery system market, by application, 2016 - 2028 (USD Million)
Table 81 South Africa Buccal drug delivery system market, by end user, 2016 - 2028 (USD Million)
Table 82 Saudi Arabia Buccal drug delivery system market, by type 2016 - 2028 (USD Million)
Table 83 Saudi Arabia Buccal drug delivery system market, by application, 2016 - 2028 (USD Million)
Table 84 Saudi Arabia Buccal drug delivery system market, by end user, 2016 - 2028 (USD Million)
Table 85 Turkey Buccal drug delivery system market, by type 2016 - 2028 (USD Million)
Table 86 Turkey Buccal drug delivery system market, by application, 2016 - 2028 (USD Million)
Table 87 Turkey Buccal drug delivery system market, by end user, 2016 - 2028 (USD Million)
Table 88 UAE Buccal drug delivery system market, by type 2016 - 2028 (USD Million)
Table 89 UAE Buccal drug delivery system market, by application, 2016 - 2028 (USD Million)
Table 90 UAE Buccal drug delivery system market, by end user, 2016 - 2028 (USD Million)
LIST OF FIGURE
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in North America
Fig. 5 Primary interviews in Europe
Fig. 6 Primary interviews in APAC
Fig. 7 Primary interviews in Latin America
Fig. 8 Primary interviews in MEA
Fig. 9 Market research approaches
Fig. 10 Value-chain-based sizing & forecasting
Fig. 11 QFD modeling for market share assessment
Fig. 12 Market formulation & validation
Fig. 13 Buccal drug delivery system market: market outlook
Fig. 14 Buccal drug delivery system market competitive insights
Fig. 15 Parent market outlook
Fig. 16 Related/ancillary market outlook
Fig. 17 Penetration and growth prospect mapping
Fig. 18 Industry value chain analysis
Fig. 19 Buccal drug delivery system market driver impact
Fig. 20 Buccal drug delivery system market restraint impact
Fig. 21 Buccal drug delivery system market strategic initiatives analysis
Fig. 22 Buccal drug delivery system market: type movement analysis
Fig. 23 Buccal drug delivery system market: type outlook and key takeaways
Fig. 24 Sublingual films market estimates and forecast, 2016 - 2028
Fig. 25 Buccal tablets and lozenges Based market estimates and forecast, 2016 - 2028
Fig. 26 Oral Sprays Based market estimates and forecast, 2016 - 2028
Fig. 27 Buccal drug delivery system market: application movement analysis
Fig. 28 Buccal drug delivery system market: application outlook and key takeaways
Fig. 29 Pain Management Market Estimates and Forecast, 2016 - 2028
Fig. 30 Smoking Cessation Market Estimates and Forecast, 2016 - 2028
Fig. 31 Angina Pectoris Market Estimates and Forecast, 2016 – 2028
Fig. 32 Others Estimates and Forecast, 2016 - 2028
Fig. 33 Buccal drug delivery system Market: End-user Analysis
Fig. 34 Buccal drug delivery system Market: End-user outlook and key takeaways
Fig. 35 Hospitals Market Estimates and Forecast, 2016 - 2028
Fig. 36 Ambulatory Centers Market Estimates and Forecast, 2016 - 2028
Fig. 37 Others Market Estimates and Forecast, 2016 – 2028
Fig. 38 Global Buccal drug delivery system market: regional movement analysis
Fig. 39 Global Buccal drug delivery system market: regional outlook and key takeaways
Fig. 40 Global market share and leading players
Fig. 41 North America market share and leading players
Fig. 42 Europe market share and leading players
Fig. 43 Asia Pacific market share and leading players
Fig. 44 Latin America market share and leading players
Fig. 45 Middle East & Africa market share and leading players
Fig. 46 North America: SWOT
Fig. 47 Europe SWOT
Fig. 48 Asia Pacific SWOT
Fig. 49 Latin America SWOT
Fig. 50 MEA SWOT
Fig. 51 North America, by country
Fig. 52 North America
Fig. 53 North America market estimates and forecast, 2016 - 2028
Fig. 54 U.S.
Fig. 55 U.S. market estimates and forecast, 2016 - 2028
Fig. 56 Canada
Fig. 57 Canada market estimates and forecast, 2016 - 2028
Fig. 58 Europe
Fig. 59 Europe market estimates and forecast, 2016 - 2028
Fig. 60 U.K.
Fig. 61 U.K. market estimates and forecast, 2016 - 2028
Fig. 62 Germany
Fig. 63 Germany market estimates and forecast, 2016 - 2028
Fig. 64 France
Fig. 65 France market estimates and forecast, 2016 - 2028
Fig. 66 Italy
Fig. 67 Italy market estimates and forecast, 2016 - 2028
Fig. 68 Spain
Fig. 69 Spain market estimates and forecast, 2016 - 2028
Fig. 70 Russia
Fig. 71 Russia market estimates and forecast, 2016 - 2028
Fig. 72 Sweden
Fig. 73 Sweden market estimates and forecast, 2016 - 2028
Fig. 74 Norway
Fig. 75 Norway market estimates and forecast, 2016 - 2028
Fig. 76 Asia Pacific
Fig. 77 Asia Pacific market estimates and forecast, 2016 - 2028
Fig. 78 China
Fig. 79 China market estimates and forecast, 2016 - 2028
Fig. 80 Japan
Fig. 81 Japan market estimates and forecast, 2016 - 2028
Fig. 82 India
Fig. 83 India market estimates and forecast, 2016 - 2028
Fig. 84 Thailand
Fig. 85 Thailand market estimates and forecast, 2016 - 2028
Fig. 86 South Korea
Fig. 87 South Korea market estimates and forecast, 2016 - 2028
Fig. 88 Australia
Fig. 89 Australia market estimates and forecast, 2016 - 2028
Fig. 90 Latin America
Fig. 91 Latin America market estimates and forecast, 2016 - 2028
Fig. 92 Brazil
Fig. 93 Brazil market estimates and forecast, 2016 - 2028
Fig. 94 Mexico
Fig. 95 Mexico market estimates and forecast, 2016 - 2028
Fig. 96 Argentina
Fig. 97 Argentina market estimates and forecast, 2016 - 2028
Fig. 98 Middle East and Africa
Fig. 99 Middle East and Africa market estimates and forecast, 2016 - 2028
Fig. 100 South Africa
Fig. 101 South Africa market estimates and forecast, 2016 - 2028
Fig. 102 Saudi Arabia
Fig. 103 Saudi Arabia market estimates and forecast, 2016 - 2028
Fig. 104 UAE
Fig. 105 UAE market estimates and forecast, 2016 - 2028
Fig. 106 Turkey
Fig. 107 Turkey market estimates and forecast, 2016 - 2028
Fig. 108 Participant categorization- Buccal drug delivery system market
Fig. 109 Market share of key market players- Buccal drug delivery system markets
Table 1 List of Abbreviation
Table 2 North America Buccal drug delivery system market, by country, 2016 - 2028 (USD Million)
Table 3 North America Buccal drug delivery system market, by type, 2016 - 2028 (USD Million)
Table 4 North America Buccal drug delivery system market, by application, 2016 - 2028 (USD Million)
Table 5 North America Buccal drug delivery system market, by end user, 2016 - 2028 (USD Million)
Table 6 U.S. Buccal drug delivery system market, by type 2016 - 2028 (USD Million)
Table 7 U.S. Buccal drug delivery system market, by application, 2016 - 2028 (USD Million)
Table 8 U.S. Buccal drug delivery system market, by end user, 2016 - 2028 (USD Million)
Table 9 Canada Buccal drug delivery system market, by type 2016 - 2028 (USD Million)
Table 10 Canada Buccal drug delivery system market, by application, 2016 - 2028 (USD Million)
Table 11 Canada Buccal drug delivery system market, by end user, 2016 - 2028 (USD Million)
Table 12 Europe Buccal drug delivery system market, by country, 2016 - 2028 (USD Million)
Table 13 Europe Buccal drug delivery system market, by type 2016 - 2028 (USD Million)
Table 14 Europe Buccal drug delivery system market, by application, 2016 - 2028 (USD Million)
Table 15 Europe Buccal drug delivery system market, by end user, 2016 - 2028 (USD Million)
Table 16 Germany Buccal drug delivery system market, by type 2016 - 2028 (USD Million)
Table 17 Germany Buccal drug delivery system market, by application, 2016 - 2028 (USD Million)
Table 18 Germany Buccal drug delivery system market, by end user, 2016 - 2028 (USD Million)
Table 19 France Buccal drug delivery system market, by type 2016 - 2028 (USD Million)
Table 20 France Buccal drug delivery system market, by application, 2016 - 2028 (USD Million)
Table 21 France Buccal drug delivery system market, by end user, 2016 - 2028 (USD Million)
Table 22 Italy Buccal drug delivery system market, by type 2016 - 2028 (USD Million)
Table 23 Italy Buccal drug delivery system market, by application, 2016 - 2028 (USD Million)
Table 24 Italy Buccal drug delivery system market, by end user, 2016 - 2028 (USD Million)
Table 25 Spain Buccal drug delivery system market, by type 2016 - 2028 (USD Million)
Table 26 Spain Buccal drug delivery system market, by application, 2016 - 2028 (USD Million)
Table 27 Spain a Buccal drug delivery system market, by end user, 2016 - 2028 (USD Million)
Table 28 U.K. Buccal drug delivery system market, by type 2016 - 2028 (USD Million)
Table 29 U.K. Buccal drug delivery system market, by application, 2016 - 2028 (USD Million)
Table 30 U.K. Buccal drug delivery system market, by end user, 2016 - 2028 (USD Million)
Table 31 Norway Buccal drug delivery system market, by type 2016 - 2028 (USD Million)
Table 32 Norway Buccal drug delivery system market, by application, 2016 - 2028 (USD Million)
Table 33 Norway Buccal drug delivery system market, by end user, 2016 - 2028 (USD Million)
Table 34 Sweden Buccal drug delivery system market, by type 2016 - 2028 (USD Million)
Table 35 Sweden Buccal drug delivery system market, by application, 2016 - 2028 (USD Million)
Table 36 Sweden Buccal drug delivery system market, by end user, 2016 - 2028 (USD Million)
Table 37 Russia Buccal drug delivery system market, by type 2016 - 2028 (USD Million)
Table 38 Russia Buccal drug delivery system market, by application, 2016 - 2028 (USD Million)
Table 39 Russia a Buccal drug delivery system market, by end user, 2016 - 2028 (USD Million)
Table 40 Asia Pacific Buccal drug delivery system market, by country, 2016 - 2028 (USD Million)
Table 41 Asia Pacific Buccal drug delivery system market, by type 2016 - 2028 (USD Million)
Table 42 Asia Pacific Buccal drug delivery system market, by application, 2016 - 2028 (USD Million)
Table 43 Asia Pacific Buccal drug delivery system market, by end user, 2016 - 2028 (USD Million)
Table 44 Japan Buccal drug delivery system market, by type 2016 - 2028 (USD Million)
Table 45 Japan Buccal drug delivery system market, by application, 2016 - 2028 (USD Million)
Table 46 Japan Buccal drug delivery system market, by end user, 2016 - 2028 (USD Million)
Table 47 China Buccal drug delivery system market, by type 2016 - 2028 (USD Million)
Table 48 China Buccal drug delivery system market, by application, 2016 - 2028 (USD Million)
Table 49 China Buccal drug delivery system market, by end user, 2016 - 2028 (USD Million)
Table 50 India Buccal drug delivery system market, by type 2016 - 2028 (USD Million)
Table 51 India Buccal drug delivery system market, by application, 2016 - 2028 (USD Million)
Table 52 India Buccal drug delivery system market, by end user, 2016 - 2028 (USD Million)
Table 53 Australia Buccal drug delivery system market, by type 2016 - 2028 (USD Million)
Table 54 Australia Buccal drug delivery system market, by application, 2016 - 2028 (USD Million)
Table 55 Australia Buccal drug delivery system market, by end user, 2016 - 2028 (USD Million)
Table 56 South Korea Buccal drug delivery system market, by type 2016 - 2028 (USD Million)
Table 57 South Korea Buccal drug delivery system market, by application, 2016 - 2028 (USD Million)
Table 58 South Korea Buccal drug delivery system market, by end user, 2016 - 2028 (USD Million)
Table 59 Thailand Buccal drug delivery system market, by type 2016 - 2028 (USD Million)
Table 60 Thailand Buccal drug delivery system market, by application, 2016 - 2028 (USD Million)
Table 61 Thailand Buccal drug delivery system market, by end user, 2016 - 2028 (USD Million)
Table 62 Latin America Buccal drug delivery system market, by country, 2016 - 2028 (USD Million)
Table 63 Latin America Buccal drug delivery system market, by type 2016 - 2028 (USD Million)
Table 64 Latin America Buccal drug delivery system market, by application, 2016 - 2028 (USD Million)
Table 65 Latin America Buccal drug delivery system market, by end user, 2016 - 2028 (USD Million)
Table 66 Mexico Buccal drug delivery system market, by type 2016 - 2028 (USD Million)
Table 67 Mexico Buccal drug delivery system market, by application, 2016 - 2028 (USD Million)
Table 68 Mexico Buccal drug delivery system market, by end user, 2016 - 2028 (USD Million)
Table 69 Brazil Buccal drug delivery system market, by type 2016 - 2028 (USD Million)
Table 70 Brazil Buccal drug delivery system market, by application, 2016 - 2028 (USD Million)
Table 71 Brazil Buccal drug delivery system market, by end user, 2016 - 2028 (USD Million)
Table 72 Argentina Buccal drug delivery system market, by type 2016 - 2028 (USD Million)
Table 73 Argentina Buccal drug delivery system market, by application, 2016 - 2028 (USD Million)
Table 74 Argentina Buccal drug delivery system market, by end user, 2016 - 2028 (USD Million)
Table 75 Middle East and Africa Buccal drug delivery system market, by country, 2016 - 2028 (USD Million)
Table 76 Middle East and Africa Buccal drug delivery system market, by type 2016 - 2028 (USD Million)
Table 77 Middle East and Africa Buccal drug delivery system market, by application, 2016 - 2028 (USD Million)
Table 78 Middle East and Africa Buccal drug delivery system market, by end user, 2016 - 2028 (USD Million)
Table 79 South Africa Buccal drug delivery system market, by type 2016 - 2028 (USD Million)
Table 80 South Africa Buccal drug delivery system market, by application, 2016 - 2028 (USD Million)
Table 81 South Africa Buccal drug delivery system market, by end user, 2016 - 2028 (USD Million)
Table 82 Saudi Arabia Buccal drug delivery system market, by type 2016 - 2028 (USD Million)
Table 83 Saudi Arabia Buccal drug delivery system market, by application, 2016 - 2028 (USD Million)
Table 84 Saudi Arabia Buccal drug delivery system market, by end user, 2016 - 2028 (USD Million)
Table 85 Turkey Buccal drug delivery system market, by type 2016 - 2028 (USD Million)
Table 86 Turkey Buccal drug delivery system market, by application, 2016 - 2028 (USD Million)
Table 87 Turkey Buccal drug delivery system market, by end user, 2016 - 2028 (USD Million)
Table 88 UAE Buccal drug delivery system market, by type 2016 - 2028 (USD Million)
Table 89 UAE Buccal drug delivery system market, by application, 2016 - 2028 (USD Million)
Table 90 UAE Buccal drug delivery system market, by end user, 2016 - 2028 (USD Million)
LIST OF FIGURE
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in North America
Fig. 5 Primary interviews in Europe
Fig. 6 Primary interviews in APAC
Fig. 7 Primary interviews in Latin America
Fig. 8 Primary interviews in MEA
Fig. 9 Market research approaches
Fig. 10 Value-chain-based sizing & forecasting
Fig. 11 QFD modeling for market share assessment
Fig. 12 Market formulation & validation
Fig. 13 Buccal drug delivery system market: market outlook
Fig. 14 Buccal drug delivery system market competitive insights
Fig. 15 Parent market outlook
Fig. 16 Related/ancillary market outlook
Fig. 17 Penetration and growth prospect mapping
Fig. 18 Industry value chain analysis
Fig. 19 Buccal drug delivery system market driver impact
Fig. 20 Buccal drug delivery system market restraint impact
Fig. 21 Buccal drug delivery system market strategic initiatives analysis
Fig. 22 Buccal drug delivery system market: type movement analysis
Fig. 23 Buccal drug delivery system market: type outlook and key takeaways
Fig. 24 Sublingual films market estimates and forecast, 2016 - 2028
Fig. 25 Buccal tablets and lozenges Based market estimates and forecast, 2016 - 2028
Fig. 26 Oral Sprays Based market estimates and forecast, 2016 - 2028
Fig. 27 Buccal drug delivery system market: application movement analysis
Fig. 28 Buccal drug delivery system market: application outlook and key takeaways
Fig. 29 Pain Management Market Estimates and Forecast, 2016 - 2028
Fig. 30 Smoking Cessation Market Estimates and Forecast, 2016 - 2028
Fig. 31 Angina Pectoris Market Estimates and Forecast, 2016 – 2028
Fig. 32 Others Estimates and Forecast, 2016 - 2028
Fig. 33 Buccal drug delivery system Market: End-user Analysis
Fig. 34 Buccal drug delivery system Market: End-user outlook and key takeaways
Fig. 35 Hospitals Market Estimates and Forecast, 2016 - 2028
Fig. 36 Ambulatory Centers Market Estimates and Forecast, 2016 - 2028
Fig. 37 Others Market Estimates and Forecast, 2016 – 2028
Fig. 38 Global Buccal drug delivery system market: regional movement analysis
Fig. 39 Global Buccal drug delivery system market: regional outlook and key takeaways
Fig. 40 Global market share and leading players
Fig. 41 North America market share and leading players
Fig. 42 Europe market share and leading players
Fig. 43 Asia Pacific market share and leading players
Fig. 44 Latin America market share and leading players
Fig. 45 Middle East & Africa market share and leading players
Fig. 46 North America: SWOT
Fig. 47 Europe SWOT
Fig. 48 Asia Pacific SWOT
Fig. 49 Latin America SWOT
Fig. 50 MEA SWOT
Fig. 51 North America, by country
Fig. 52 North America
Fig. 53 North America market estimates and forecast, 2016 - 2028
Fig. 54 U.S.
Fig. 55 U.S. market estimates and forecast, 2016 - 2028
Fig. 56 Canada
Fig. 57 Canada market estimates and forecast, 2016 - 2028
Fig. 58 Europe
Fig. 59 Europe market estimates and forecast, 2016 - 2028
Fig. 60 U.K.
Fig. 61 U.K. market estimates and forecast, 2016 - 2028
Fig. 62 Germany
Fig. 63 Germany market estimates and forecast, 2016 - 2028
Fig. 64 France
Fig. 65 France market estimates and forecast, 2016 - 2028
Fig. 66 Italy
Fig. 67 Italy market estimates and forecast, 2016 - 2028
Fig. 68 Spain
Fig. 69 Spain market estimates and forecast, 2016 - 2028
Fig. 70 Russia
Fig. 71 Russia market estimates and forecast, 2016 - 2028
Fig. 72 Sweden
Fig. 73 Sweden market estimates and forecast, 2016 - 2028
Fig. 74 Norway
Fig. 75 Norway market estimates and forecast, 2016 - 2028
Fig. 76 Asia Pacific
Fig. 77 Asia Pacific market estimates and forecast, 2016 - 2028
Fig. 78 China
Fig. 79 China market estimates and forecast, 2016 - 2028
Fig. 80 Japan
Fig. 81 Japan market estimates and forecast, 2016 - 2028
Fig. 82 India
Fig. 83 India market estimates and forecast, 2016 - 2028
Fig. 84 Thailand
Fig. 85 Thailand market estimates and forecast, 2016 - 2028
Fig. 86 South Korea
Fig. 87 South Korea market estimates and forecast, 2016 - 2028
Fig. 88 Australia
Fig. 89 Australia market estimates and forecast, 2016 - 2028
Fig. 90 Latin America
Fig. 91 Latin America market estimates and forecast, 2016 - 2028
Fig. 92 Brazil
Fig. 93 Brazil market estimates and forecast, 2016 - 2028
Fig. 94 Mexico
Fig. 95 Mexico market estimates and forecast, 2016 - 2028
Fig. 96 Argentina
Fig. 97 Argentina market estimates and forecast, 2016 - 2028
Fig. 98 Middle East and Africa
Fig. 99 Middle East and Africa market estimates and forecast, 2016 - 2028
Fig. 100 South Africa
Fig. 101 South Africa market estimates and forecast, 2016 - 2028
Fig. 102 Saudi Arabia
Fig. 103 Saudi Arabia market estimates and forecast, 2016 - 2028
Fig. 104 UAE
Fig. 105 UAE market estimates and forecast, 2016 - 2028
Fig. 106 Turkey
Fig. 107 Turkey market estimates and forecast, 2016 - 2028
Fig. 108 Participant categorization- Buccal drug delivery system market
Fig. 109 Market share of key market players- Buccal drug delivery system markets
